Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Le Morvan

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Bulletin Du Cancer|November 14, 2008
[Biological bases for individualising prescriptions in oncology: the germline genome]Jacques Robert, Valérie Le Morvan
European Journal of Cancer (Oxford, England : 1990)|February 24, 2007
Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panelNadège Nief, Valérie Le Morvan, Jacques Robert
Molecular Diagnosis & Therapy|July 26, 2008
Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitroStéphane Puyo, Valérie Le Morvan, Jacques Robert
Bulletin Du Cancer|December 14, 2021
[Normal organoids and their applications in cancer research]Frederic Delom, Valérie Le Morvan, Jacques Robert, et al.
Oncology Reports|March 29, 2007
Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicityDelphine Meynard, Valérie Le Morvan, Jacques Bonnet, et al.
Molecular Cancer Therapeutics|October 5, 2010
Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro modelsAudrey Laroche-Clary, Valérie Le Morvan, Takao Yamori, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2014
On the use of pharmacogenetics in cancer treatment and clinical trialsJacques Robert, Valérie Le Morvan, Elisa Giovannetti, et al.
Critical Reviews in Oncology/Hematology|May 14, 2005
Predicting drug response and toxicity based on gene polymorphismsJacques Robert, Valérie Le Morvan, Denis Smith, et al.
Lipids|October 10, 2002
n-3 FA increase liver uptake of HDL-cholesterol in miceValérie le Morvan, Marie-France Dumon, Antonio Palos-Pinto, et al.
Toxicology|September 18, 2012
Short curcumin treatment modulates oxidative stress, arginase activity, aberrant crypt foci, and TGF-β1 and HES-1 transcripts in 1,2-dimethylhydrazine-colon carcinogenesis in miceAbdelkader Bounaama, Bahia Djerdjouri, Audrey Laroche-Clary, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|November 14, 2008
[Biological bases for individualising prescriptions in oncology: the germline genome]Jacques Robert, Valérie Le Morvan
European Journal of Cancer (Oxford, England : 1990)|February 24, 2007
Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panelNadège Nief, Valérie Le Morvan, Jacques Robert
Molecular Diagnosis & Therapy|July 26, 2008
Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitroStéphane Puyo, Valérie Le Morvan, Jacques Robert
Bulletin Du Cancer|December 14, 2021
[Normal organoids and their applications in cancer research]Frederic Delom, Valérie Le Morvan, Jacques Robert, et al.
Oncology Reports|March 29, 2007
Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicityDelphine Meynard, Valérie Le Morvan, Jacques Bonnet, et al.
Molecular Cancer Therapeutics|October 5, 2010
Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro modelsAudrey Laroche-Clary, Valérie Le Morvan, Takao Yamori, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2014
On the use of pharmacogenetics in cancer treatment and clinical trialsJacques Robert, Valérie Le Morvan, Elisa Giovannetti, et al.
Critical Reviews in Oncology/Hematology|May 14, 2005
Predicting drug response and toxicity based on gene polymorphismsJacques Robert, Valérie Le Morvan, Denis Smith, et al.
Lipids|October 10, 2002
n-3 FA increase liver uptake of HDL-cholesterol in miceValérie le Morvan, Marie-France Dumon, Antonio Palos-Pinto, et al.
Toxicology|September 18, 2012
Short curcumin treatment modulates oxidative stress, arginase activity, aberrant crypt foci, and TGF-β1 and HES-1 transcripts in 1,2-dimethylhydrazine-colon carcinogenesis in miceAbdelkader Bounaama, Bahia Djerdjouri, Audrey Laroche-Clary, et al.
Pageof 4